This is a synthetic peptide designed for use in combination with anti-PLD3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
PLD3
(Phospholipase D family member 3 (PLD3))
Synonymes
DDBDRAFT_0204850 Peptide, DDBDRAFT_0231505 Peptide, DDB_0204850 Peptide, DDB_0231505 Peptide, DDBDRAFT_0187542 Peptide, DDBDRAFT_0220113 Peptide, DDB_0187542 Peptide, DDB_0220113 Peptide, HU-K4 Peptide, HUK4 Peptide, Sam-9 Peptide, phospholipase D3 Peptide, phospholipase D family member 3 Peptide, phospholipase D family, member 3 Peptide, CpipJ_CPIJ017227 Peptide, pldZ Peptide, pldY Peptide, DICPUDRAFT_30308 Peptide, PLD3 Peptide, Pld3 Peptide
Sujet
This gene encodes a member of the phospholipase D (PLD) family of enzymes that catalyze the hydrolysis of membrane phospholipids. The encoded protein is a single-pass type II membrane protein and contains two PLD phosphodiesterase domains. This protein influences processing of amyloid-beta precursor protein. Mutations in this gene are associated with Alzheimer disease risk. Alternatively spliced transcript variants encoding the same protein have been found for this gene.